← Publication index
Early treatment with fluvoxamine among patients with COVID-19: a cost-consequence model
FP Mills, G Reis, LA Wilson, K Thorlund, ...
To date, two published randomized trials have indicated a clinical benefit of early treatment with fluvoxamine versus placebo for adults with symptomatic COVID-19. Using the results of …
Nearby in the record
- The Effect of Fluvoxamine and Metformin for Fatigue in Patients With Long COVID
- Resilient Clinical Trial Infrastructure in Response to the COVID-19 Pandemic: Lessons Learned from the TOGETHER Randomized Platform Clinical Trial
- Effect of spirulina on risk of hospitalization among patients with COVID-19: the TOGETHER randomized trial